Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: SEENSCO
$10.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Updates FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance


Wednesday, 17 Apr 2013 07:00am EDT 

Quest Diagnostics Inc announced that for fiscal 2013, it expects revenue to approximate the prior year level, compared to previous guidance of 0% to 1% growth and earnings per diluted share (EPS) to be between $4.35 and $4.55, unchanged from prior guidance. The Company reported revenues of $7.382 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $7.38 billion and EPS of $4.41 for fiscal 2013. 

Company Quote

64.34
0.82 +1.29%
11:20am EST